Bladder cancer research highlights from EAU24

The European Association of Urology 2024 (EAU24) is Europe’s largest Annual Urology Congress which took place on April 5-8, in Paris, France.  

We have selected three bladder cancer research studies presented at EAU24, with lay summaries of each study provided below. 

Localised chemotherapy for people with high-risk, non-muscle-invasive bladder cancer

The SunRISe-1 study is evaluating the effectiveness and safety of TAR-200, a new treatment for people with high-risk non-muscle-invasive bladder cancer who found that standard BCG treatment didn’t work for them and who are unable to have surgery (cystectomy).

World Bladder Cancer Patient Forum 2021 – September 22

Join us for the first World Bladder Cancer Patient Forum 2021, taking place virtually this year with the theme “Changing bladder cancer patient care together.”   

The World Bladder Cancer Patient Forum will bring together leading voices from around the world to discuss the role of bladder cancer patient voice from research design to treatment and care.

Our member organisations will showcase key projects from their communities, which are positively impacting people affected by bladder cancer.